BioCentury
ARTICLE | Company News

Maxygen, sanofi-aventis deal

December 10, 2007 8:00 AM UTC

MAXY granted SAN's sanofi pasteur vaccines unit an exclusive, worldwide license to dengue virus antigen technology, including a portfolio of preclinical dengue antigens, to develop and commercialize a...